Advertisement
Home »

A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score.

Jan 15, 2024

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE EXPERTS

  • Zixuan Zhao

    Department of Public Administration, School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.

    Shuyan Gu

    Center for Health Policy and Management Studies, School of Government, Nanjing University, Nanjing, China.

    Yi Yang

    Department of Science and Education of the Fourth Affiliated Hospital, and Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.

    Weijia Wu

    Department of Science and Education of the Fourth Affiliated Hospital, and Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.

    Lingbin Du

    Department of Cancer Prevention, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences/Cancer Hospital of the University of Chinese Academy of Sciences/Zhejiang Cancer Hospital, Hangzhou, China.

    Gaoling Wang

    Department of Public Administration, School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China. 280097@njucm.edu.cn.

    Hengjin Dong

    Department of Science and Education of the Fourth Affiliated Hospital, and Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China. donghj@zju.edu.cn.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement